| 000 | 01461 a2200409 4500 | ||
|---|---|---|---|
| 005 | 20250513143016.0 | ||
| 264 | 0 | _c19980702 | |
| 008 | 199807s 0 0 eng d | ||
| 022 | _a0066-4804 | ||
| 024 | 7 |
_a10.1128/AAC.42.5.1088 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aEliopoulos, G M | |
| 245 | 0 | 0 |
_aCharacterization of vancomycin-resistant Enterococcus faecium isolates from the United States and their susceptibility in vitro to dalfopristin-quinupristin. _h[electronic resource] |
| 260 |
_bAntimicrobial agents and chemotherapy _cMay 1998 |
||
| 300 |
_a1088-92 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 |
_aAnti-Bacterial Agents _xpharmacology |
| 650 | 0 | 4 | _aDrug Resistance, Microbial |
| 650 | 0 | 4 |
_aEnterococcus faecium _xdrug effects |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMicrobial Sensitivity Tests |
| 650 | 0 | 4 | _aUnited States |
| 650 | 0 | 4 |
_aVancomycin _xpharmacology |
| 650 | 0 | 4 |
_aVirginiamycin _xpharmacology |
| 700 | 1 | _aWennersten, C B | |
| 700 | 1 | _aGold, H S | |
| 700 | 1 | _aSchülin, T | |
| 700 | 1 | _aSouli, M | |
| 700 | 1 | _aFarris, M G | |
| 700 | 1 | _aCerwinka, S | |
| 700 | 1 | _aNadler, H L | |
| 700 | 1 | _aDowzicky, M | |
| 700 | 1 | _aTalbot, G H | |
| 700 | 1 | _aMoellering, R C | |
| 773 | 0 |
_tAntimicrobial agents and chemotherapy _gvol. 42 _gno. 5 _gp. 1088-92 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1128/AAC.42.5.1088 _zAvailable from publisher's website |
| 999 |
_c9559890 _d9559890 |
||